Differential research impact in cancer practice guidelines' evidence base: lessons from ESMO, NICE and SIGN.

Elena PallariAnthony W FoxGrant Lewison

Published in: ESMO open (2018)

We showed that ESMO, NICE and SIGN differ in their evidence base of CPGs. Healthcare professionals should be aware of this heterogeneity in effective decision-making of tailored treatments to patients, irrespective of geographic location across Europe.

Keyphrases

decision making
end stage renal disease
ejection fraction
newly diagnosed
healthcare
primary care
papillary thyroid
prognostic factors
peritoneal dialysis
young adults
patient reported outcomes
lymph node metastasis
smoking cessation
patient reported